Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of exenatide on cortisol secretion in healthy volunteers
2017-001437-12Phase 4Completed
- Sponsor
- University of Tartu
- Start
- Apr 2017
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, single-arm trial of exenatide, sponsored by University of Tartu. Primary endpoint: Maximum cortisol level after exenatide. Started Apr 2017; status: completed.
02
Drugs
exenatide
Beyond the preview
Go deeper on 2017-001437-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-001437-12.